
Prodrugs are pharmacologically inert and nontoxic chemical compounds which are transformed in vivo into pharmacologically and therapeutically active compounds, i.e. drugs. Prodrugs are used to solve problems which cannot be solved by the drugs themselves. There are three types of problems: problems arising before the drug enters the body (solubilization, stabilization and improved acceptability); problems associated with the penetration and fate of the drug in the body (absorption, barrier crossing, duration of action); problems relating to the therapeutic target (selective local delivery). The principal prodrugs that solve these problems and the mechanisms of the solutions they provide are described and discussed.
Chemical Phenomena, Drug Resistance, Administration, Oral, Angiotensin-Converting Enzyme Inhibitors, Antineoplastic Agents, Injections, Intramuscular, Pivampicillin, Chemistry, Sulindac, Intestinal Absorption, Liver, Blood-Brain Barrier, Molsidomine, Azacitidine, Ampicillin, Prodrugs
Chemical Phenomena, Drug Resistance, Administration, Oral, Angiotensin-Converting Enzyme Inhibitors, Antineoplastic Agents, Injections, Intramuscular, Pivampicillin, Chemistry, Sulindac, Intestinal Absorption, Liver, Blood-Brain Barrier, Molsidomine, Azacitidine, Ampicillin, Prodrugs
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
